Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harold R Almond

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Biopolymers|February 13, 2003
Gaussian docking functionsMark R McGann, Harold R Almond, Anthony Nicholls, et al.
Journal of the American Chemical Society|April 11, 2002
Nonpeptide inhibitors of cathepsin G: optimization of a novel beta-ketophosphonic acid lead by structure-based drug designMichael N Greco, Michael J Hawkins, Eugene T Powell, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 19, 2008
Thrombogenic collagen-mimetic peptides: Self-assembly of triple helix-based fibrils driven by hydrophobic interactionsMabel A Cejas, William A Kinney, Cailin Chen, et al.
Journal of Medicinal Chemistry|August 22, 2003
Potent, small-molecule inhibitors of human mast cell tryptase. Antiasthmatic action of a dipeptide-based transition-state analogue containing a benzothiazole ketoneMichael J Costanzo, Stephen C Yabut, Harold R Almond, et al.
Angewandte Chemie (International Ed. in English)|August 31, 2002
Structure-function analysis of urotensin II and its use in the construction of a ligand-receptor working modelWilliam A Kinney, Harold R Almond, Jenson Qi, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2007
Phenylpiperidine-benzoxazinones as urotensin-II receptor antagonists: synthesis, SAR, and in vivo assessmentDiane K Luci, Shyamali Ghosh, Charles E Smith, et al.
Journal of Medicinal Chemistry|March 17, 2007
Discovery of potent, selective, orally active, nonpeptide inhibitors of human mast cell chymaseMichael N Greco, Michael J Hawkins, Eugene T Powell, et al.
Journal of Medicinal Chemistry|March 18, 2005
In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug designMichael J Costanzo, Harold R Almond, Leonard R Hecker, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biopolymers|February 13, 2003
Gaussian docking functionsMark R McGann, Harold R Almond, Anthony Nicholls, et al.
Journal of the American Chemical Society|April 11, 2002
Nonpeptide inhibitors of cathepsin G: optimization of a novel beta-ketophosphonic acid lead by structure-based drug designMichael N Greco, Michael J Hawkins, Eugene T Powell, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 19, 2008
Thrombogenic collagen-mimetic peptides: Self-assembly of triple helix-based fibrils driven by hydrophobic interactionsMabel A Cejas, William A Kinney, Cailin Chen, et al.
Journal of Medicinal Chemistry|August 22, 2003
Potent, small-molecule inhibitors of human mast cell tryptase. Antiasthmatic action of a dipeptide-based transition-state analogue containing a benzothiazole ketoneMichael J Costanzo, Stephen C Yabut, Harold R Almond, et al.
Angewandte Chemie (International Ed. in English)|August 31, 2002
Structure-function analysis of urotensin II and its use in the construction of a ligand-receptor working modelWilliam A Kinney, Harold R Almond, Jenson Qi, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2007
Phenylpiperidine-benzoxazinones as urotensin-II receptor antagonists: synthesis, SAR, and in vivo assessmentDiane K Luci, Shyamali Ghosh, Charles E Smith, et al.
Journal of Medicinal Chemistry|March 17, 2007
Discovery of potent, selective, orally active, nonpeptide inhibitors of human mast cell chymaseMichael N Greco, Michael J Hawkins, Eugene T Powell, et al.
Journal of Medicinal Chemistry|March 18, 2005
In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug designMichael J Costanzo, Harold R Almond, Leonard R Hecker, et al.
Pageof 1